Celtura
Human pandemic influenza vaccine
Product Details
WHO Product ID
FVP-P-210
Status
Prequalified
Date of prequalification
Vaccine type
Human pandemic influenza vaccine
Abbreviated Name
IIVPandemic
Commercial Name
Celtura
PQ Holder
Germany
NRA of record
Paul Ehrlich Institute
Product description
Pharmaceutical Form
Liquid: Ready to use
Presentation
Vial
Number of doses
17
Route of administration
Intramuscular
Vaccine Vial Monitor
None
Shelf-life
6 months
Storage temperature
2 - 8°C
Diluent
N/A
Preservative
Thiomersal
Preservative concentration
0.1mg/mL
Multidose Vial Policy
WHO recommends that opened vials of this vaccine may be used in subsequent immunization sessions (up to 28 days) if the conditions outlined in the WHO Policy Statement are met.
Remarks
There is no routine production for this vaccine.
Product Packaging
Secondary Container
Tertiary Container
Shipping Container
Component Packed
Active (Vaccine)
Total doses
10
Description
10
Cold Chain Volume (cm³/dose)
0.0